Pliant Therapeutics Statistics

Total Valuation

PLRX has a market cap or net worth of $94.53 million. The enterprise value is -$150.94 million.

Market Cap	94.53M
Enterprise Value	-150.94M

Important Dates

The last earnings date was Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

PLRX has 61.39 million shares outstanding. The number of shares has increased by 1.76% in one year.

Current Share Class	61.39M
Shares Outstanding	61.39M
Shares Change (YoY)	+1.76%
Shares Change (QoQ)	+0.61%
Owned by Insiders (%)	3.04%
Owned by Institutions (%)	86.37%
Float	54.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.37
P/TBV Ratio	0.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.03, with a Debt / Equity ratio of 0.23.

Current Ratio	11.03
Quick Ratio	10.90
Debt / Equity	0.23
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-69.54

Financial Efficiency

Return on equity (ROE) is -63.22% and return on invested capital (ROIC) is -36.28%.

Return on Equity (ROE)	-63.22%
Return on Assets (ROA)	-33.89%
Return on Invested Capital (ROIC)	-36.28%
Return on Capital Employed (ROCE)	-74.20%
Revenue Per Employee	n/a
Profits Per Employee	-$1.28M
Employee Count	171
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.19% in the last 52 weeks. The beta is 1.36, so PLRX's price volatility has been higher than the market average.

Beta (5Y)	1.36
52-Week Price Change	-86.19%
50-Day Moving Average	1.44
200-Day Moving Average	8.22
Relative Strength Index (RSI)	53.06
Average Volume (20 Days)	1,153,039

Short Selling Information

The latest short interest is 5.04 million, so 8.21% of the outstanding shares have been sold short.

Short Interest	5.04M
Short Previous Month	5.15M
Short % of Shares Out	8.21%
Short % of Float	9.31%
Short Ratio (days to cover)	7.23

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-234.91M
Pretax Income	n/a
Net Income	-219.52M
EBITDA	-232.85M
EBIT	-234.91M
Earnings Per Share (EPS)	-$3.61

Full Income Statement

Balance Sheet

The company has $305.65 million in cash and $60.17 million in debt, giving a net cash position of $245.47 million or $4.00 per share.

Cash & Cash Equivalents	305.65M
Total Debt	60.17M
Net Cash	245.47M
Net Cash Per Share	$4.00
Equity (Book Value)	257.16M
Book Value Per Share	4.19
Working Capital	282.99M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$174.10 million and capital expenditures -$2.62 million, giving a free cash flow of -$176.71 million.

Operating Cash Flow	-174.10M
Capital Expenditures	-2.62M
Free Cash Flow	-176.71M
FCF Per Share	-$2.88

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PLRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.76%
Shareholder Yield	-1.76%
Earnings Yield	-232.21%
FCF Yield	-186.93%

Analyst Forecast

The average price target for PLRX is $9.79, which is 535.71% higher than the current price. The consensus rating is "Hold".

Price Target	$9.79
Price Target Difference	535.71%
Analyst Consensus	Hold
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1